Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk

International Journal of Cancer

Volumn 131, Issue 9, 2012, Pages 2126-2133

  Tosovic, Ada ^a   Becker, Charlotte ^a   Bondeson, Anne Greth ^a   Bondeson, Lennart ^a   Ericsson, Ulla Britt ^a   Malm, Johan ^a   Manjer, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

breast cancer risk; thyroid peroxidase antibodies; thyroxin

Indexed keywords

LIOTHYRONINE; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID PEROXIDASE ANTIBODY BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

AUTOANTIBODIES; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; HUMANS; IODIDE PEROXIDASE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84865574057     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27470     Document Type: Article

References (49)

1. Simon MS, Tang MT, Bernstein L, Norman SA, Weiss L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone K, Marchbanks PA, McDonald JA, et al. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 2002; 11: 1574-8. (Pubitemid 36020009)
2. Kalache A, Vessey MP, McPherson K,. Thyroid disease and breast cancer: findings in a large case-control study. Br J Surg 1982; 69: 434-5. (Pubitemid 12045433)
3. Brinton LA, Hoffman DA, Hoover R, Fraumeni JF, Jr,. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis 1984; 37: 877-93. (Pubitemid 15153987)
4. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C,. Selected medical conditions and risk of breast cancer. Br J Cancer 1997; 75: 1699-703. (Pubitemid 27229065)
5. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P,. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781-5. (Pubitemid 20328547)
6. Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB,. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999; 28: 816-23. (Pubitemid 29525019)
7. Goldman MB, Monson RR, Maloof F,. Benign thyroid diseases and the risk of death from breast cancer. Oncology 1992; 49: 461-6. (Pubitemid 23003111)
8. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN,. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 2005; 103: 1122-8. (Pubitemid 40328081)
9. Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR,. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 2005; 38: 761-5. (Pubitemid 40867516)
10. Turken O, Narin Y, Demirbas S, Onde ME, Sayan O, Kandemir EG, Yaylac IM, Ozturk A,. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003; 5: R110-3.
11. Lemaire M, Baugnet-Mahieu L,. Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol 1986; 22: 301-7. (Pubitemid 16127868)
12. Zumoff B, O'Connor J, Levin J, Markham M, Strain GW, Fukushima DK,. Plasma levels of thyroxine and triiodothyronine in women with breast cancer. Anticancer Res 1981; 1: 287-91. (Pubitemid 12174412)
13. Cengiz O, Bozkurt B, Unal B, Yildirim O, Karabeyoglu M, Eroglu A, Kocer B, Ulas M,. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 2004; 87: 19-25. (Pubitemid 38880275)
14. Takatani O, Okumoto T, Kosano H, Nishida M, Hiraide H, Tamakuma S,. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res 1989; 49: 3109-12. (Pubitemid 19148653)
15. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F, Cecchetti D, Martino E, Pinchera A,. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996; 81: 990-4. (Pubitemid 26083958)
16. Smyth PP,. Thyroid disease and breast cancer. J Endocrinol Invest 1993; 16: 396-401. (Pubitemid 23197254)
17. Rasmusson B, Feldt-Rasmussen U, Hegedus L, Perrild H, Bech K, Hoier-Madsen M,. Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 1987; 23: 553-6. (Pubitemid 17057387)
18. Rose DP, Davis TE,. Plasma triiodothyronine concentrations in breast cancer. Cancer 1979; 43: 1434-8. (Pubitemid 9180311)
19. Adami HO, Rimsten A, Thoren L, Vegelius J, Wide L,. Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand 1978; 144: 89-97. (Pubitemid 8346063)
20. Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF, O'Higgins NJ,. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 1998; 83: 2711-6. (Pubitemid 28493765)
21. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, Giani C,. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006; 154: 645-9. (Pubitemid 43810849)
22. Rose DP, Davis TE,. Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. Cancer 1978; 41: 666-9.
23. Abe R, Hirosaki A, Kimura M,. Pituitary-thyroid function in patients with breast cancer. Tohoku J Exp Med 1980; 132: 231-6. (Pubitemid 11170868)
24. Kuijpens JL, Nyklictek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW,. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 2005; 15: 1253-9. (Pubitemid 41821759)
25. Hellevik AI, Asvold BO, Bjoro T, Romundstad PR, Nilsen TI, Vatten LJ,. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 2009; 18: 570-4.
26. Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J,. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Breast Cancer Res 2010; 12: R33.
27. Dinda S, Sanchez A, Moudgil V,. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 2002; 21: 761-8. (Pubitemid 34146288)
28. Conde I, Paniagua R, Zamora J, Blanquez MJ, Fraile B, Ruiz A, Arenas MI,. Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol 2006; 17: 60-4. (Pubitemid 43033841)
29. Hall LC, Salazar EP, Kane SR, Liu N,. Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 2008; 109: 57-66.
30. Luidens MK, Mousa SA, Davis FB, Lin HY, Davis PJ,. Thyroid hormone and angiogenesis. Vascul Pharmacol 2010; 52: 142-5.
31. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ,. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004; 94: 1500-6. (Pubitemid 38780323)
32. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G,. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001; 10: 489-99. (Pubitemid 34048904)
33. Manjer J, Elmstahl S, Janzon L, Berglund G,. Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Scand J Public Health 2002; 30: 103-12. (Pubitemid 41007501)
34. Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P,. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control 2003; 14: 599-607. (Pubitemid 37211116)
35. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J,. Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer 2010; 127: 2159-68.
36. Agarwal DP, Soni TP, Sharma OP, Sharma S,. Synchronous malignancies of breast and thyroid gland: a case report and review of literature. J Cancer Res Ther 2007; 3: 172-3. (Pubitemid 350293677)
37. Goldman MB,. Thyroid diseases and breast cancer. Epidemiol Rev 1990; 12: 16-28.
38. Sarlis NJ, Gourgiotis L, Pucino F, Tolis GJ,. Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones (Athens) 2002; 1: 35-41.
39. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-27.
40. Cleary MP, Grossmann ME,. Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 2009; 150: 2537-42.
41. Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O'Higgins NJ,. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab 1996; 81: 937-41. (Pubitemid 26083950)
42. Smyth PP,. The thyroid, iodine and breast cancer. Breast Cancer Res 2003; 5: 235-8. (Pubitemid 37080851)
43. Garne. Invasive breast cancer in Malmö 1961-1992-an epidemiological study. Dissertation, Lund University, Sweden, 1996.
44. The National board of Health and Welfare. Mammography-questions and answers (in Swedish) http://www.sos.se/FULLTEXT/114/2002-114-5/2002-114-5.htm. Accessed 17 Dec 2008.
45. Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP, Ross RJ,. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab 2008; 93: 2300-6. (Pubitemid 351831551)
46. Ankrah-Tetteh T, Wijeratne S, Swaminathan R,. Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1. Ann Clin Biochem 2008; 45: 167-9. (Pubitemid 351724588)
47. Andersen S, Pedersen KM, Bruun NH, Laurberg P,. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-72. (Pubitemid 36121067)
48. Mannisto T, Suvanto E, Surcel HM, Ruokonen A,. Thyroid hormones are stable even during prolonged frozen storage. Clin Chem Lab Med 2010; 48: 1669-70; author reply 71-2.
49. Mannisto T, Surcel HM, Bloigu A, Ruokonen A, Hartikainen AL, Jarvelin MR, Pouta A, Vaarasmaki M, Suvanto-Luukkonen E,. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem 2007; 53: 1986-7. (Pubitemid 350036052)